Abstract
In this study, the synthetic way to new N-pyridinyl(methyl)indolylpropanamides acting as non acidic NSAIDs has been described. Pharmacomodulation was carried out at N1 and C5 of the indole ring and at the level of the propanamide chain. N3-pyridinylmethyl-[1(4-chlorobenzyl-5-chloroindol-3-yl)propanamide represents one of the most potent compounds in the TPA-induced mouse ear swelling assay, with a level of activity higher than that of ibuprofen and comparable to that of dexamethasone.
Acknowledgements
The authors deeply appreciate the helpful technical assistance of Catherine Chauvet for the pharmacological assays.
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.